Cost analysis of a patient blood management program for patients undergoing gastric cancer surgery

Published:September 19, 2022DOI:


      • This multicentre study on 789 patients submitted to gastric cancer surgery found that implementation of a Patient Blood Management program was associated to a expense reduction of −1955 € per patient [95% CI -3764, −119] in healthcare, and of −2243 € [95% CI -4244, −210] in societal costs.
      • The main drivers of this economic saving were reductions in hospital stay, blood transfusions, and post-operative complications.


      Patient Blood Management (PBM) programs have probed to reduce blood transfusions and postoperative complications following gastric cancer resection, but evidence on their economic benefit is scarce. A recent prospective interventional study of our group described a reduction in transfusions, infectious complications and length of stay after implementation of a multicenter PBM program in patients undergoing elective gastric cancer resection with curative intent. The aim of the present study was to analyze the economic impact associated with these clinical benefits. The mean [and 95% CI] of total healthcare cost per patient was lower (−1955 [-3764, −119] €) after the PBM program implementation. The main drivers of this reduction were the hospital stay (−1847 [-3161, −553] €), blood transfusions (−100 [-145, −56] €), and post-operative complications (−162 [-718, 411] €). Total societal cost was reduced by −2243 [-4244, −210] € per patient. These findings highlight the potential economic benefit of PBM strategies.


      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to European Journal of Surgical Oncology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Sun C.
        • Wang Y.
        • Yao H.S.
        • Hu Z.Q.
        Allogenic blood transfusion and the prognosis of gastric cancer patients: systematic review and meta-analysis.
        Int J Surg. 2015; 13: 102-110
        • Agnes A.
        • Lirosi M.C.
        • Panunzi S.
        • Santocchi P.
        • Persiani R.
        • D'Ugo D.
        • et al.
        The prognostic role of perioperative allogeneic blood transfusions in gastric cancer patients undergoing curative resection: a systematic review and meta-analysis of non-randomized, adjusted studies.
        Eur J Surg Oncol. 2018; 44: 404-419
        • Isbister J.P.
        The three-pillar matrix of patient blood management. International Society of Blood Transfusion.
        Science. 2015; 10: 286-294
        • Isbister J.P.
        The three-pillar matrix of patient blood management-an overview.
        Best Pract Res Clin Anaesthesiol. 2013; 27: 69-84
        • Osorio J.
        • Jericó C.
        • Miranda C.
        • Santamaria M.
        • Artigau E.
        • Galofré G.
        • et al.
        Improved postoperative outcomes and reduced transfusion rates after implementation of a Patient Blood Management program in gastric cancer surgery.
        Eur J Oncol. 2021; 47: 1449-1457
        • Kleinerüschkamp A.
        • Meybohm P.
        • Straub N.
        • Zacharowski K.
        • Choorapoikayil S.
        A model-based cost-effectiveness analysis of Patient Blood Management.
        Blood Transfus. 2019; 17: 16-26
        • Ejaz A.
        • Frank S.M.
        • Spolverato G.
        • Kim Y.
        • Pawlik M.
        Potential economic impact of using a restrictive transfusion trigger among patients undergoing major abdominal surgery.
        JAMA Surg. 2015; 15: 625-630
        • Leahy M.F.
        • Hofmann A.
        • Towler S.
        • Trentino K.M.
        • Burrows S.A.
        • Swain S.G.
        • et al.
        Improved outcomes and reduced costs associated with a health-system-wide patient blood management program: a retrospective observational study in four major adult tertiary-care hospitals.
        Transfusion. 2017; 57: 1347-1358
        • Dal Cero M.
        • Rodríguez-Santiago J.
        • Miró M.
        • Castro S.
        • Miranda C.
        • Santamaría M.
        • et al.
        Evaluation of data quality in the Spanish EURECCA esophagogastric cancer registry.
        Eur J Oncol. 2021; 47: 3081-3087
        • De Salut Departament
        ORDRE SLT/71/2020, de 2 de juny, per la qual es regulen els supòsits i conceptes facturables i s’aproven els preus públics corresponents als serveis que presta l'Institut Català de la Salut.
        DOGC. 2020; 8153: 1-172
      1. Departament de Salut (Generalitat de Catalunya). Banc de sang i teixits. Published online 2021: Professionals. Accessed April 22, 2021.

      2. Nomenclator. Published online 2021.

        • Gómez-Rosado J.C.
        • Salas-Turrens J.
        • Olry-de-Labry-Lima A.
        Economic costs analysis related to complications in general and digestive surgery.
        Cir Esp. 2018; 96: 292-299
      3. Secretaría de Estado de Economía y Apoyo a la Empresa M de AEyTDigital. INE (Instituto Nacional de Estadística). Accessed April 22, 2021.

        • Clavien P.A.
        • Barkun J.
        • de Oliveira M.L.
        • Vauthey J.N.
        • Dindo D.
        • Schulik R.D.
        • et al.
        The Clavien-Dindo classification of surgical complications: five-year experience.
        Ann Surg. 2009; 250: 187-196
        • Efron B.
        • Tibshirani T.
        An introduction to the bootstrap.
        Chapman; Hall, 1993
        • R Core Team
        R: a language and environment for statistical computing.
        R Foundation for Statistical Computing, 2021
        • Frank S.M.
        • Savage W.J.
        • Rothschild J.A.
        • Rivers J.R.
        • Ness M.P.
        • Paul L.S.
        • et al.
        Variability in blood and blood component utilization as assessed by an anesthesia information management system.
        Anesthesiology. 2012; 117: 99-106
        • Fischer J.P.
        • Nelson J.A.
        • Sieber B.
        • Stransky C.
        • Kovach J.S.
        • Sarletti M.J.
        • et al.
        Transfusions in autologous breast reconstructions: an analysis of risk factors, complications, and cost.
        Ann Plast Surg. 2014; 72: 566-571
        • Politsmakher A.
        • Doddapaneni V.
        • Seeratan R.
        • Dosik H.
        Effective reduction of blood product use in a community teaching hospital: when less is more.
        Am J Med. 2013; 126: 894-902
        • Bolcato M.
        • Russo M.
        • Trentino K.
        • Isbister J.
        • Rodriguez D.
        • Aprile A.
        Patient blood management: the best approach to transfusion medicine risk management.
        Transfus Apher Sci. 2020; 59102779